All Stories

  1. Gender difference in response predictors after 1-year exenatide therapy twice daily in type 2 diabetic patients: a real world experience

    Article • Diabetes Metabolic Syndrome and Obesity, April 2013, Taylor & Francis

    Dr Fabio Baccetti